CXCR1 and acute myeloid leukemia: The association between higher expression of CXCR2 ligands and CXCR1 and CXCR2 receptors on AML cells and poorer prognosis suggests a potential therapeutic target in anti-leukemic therapy (Table 2 and Table 3).